vimarsana.com

Latest Breaking News On - Andrewt serafini - Page 1 : vimarsana.com

Pushing Boundaries When Patenting Ranges | Kilpatrick Townsend & Stockton LLP

Navigating Key Differences in Therapeutic Antibody Patent Protection Strategies Between the United States and Europe | Kilpatrick Townsend & Stockton LLP

To embed, copy and paste the code into your website or blog: Many of today’s top-selling drugs worldwide are therapeutic antibodies thus antibody-related inventions can be extremely valuable. Developing antibody therapeutics requires significant resources and time, so it is paramount to develop a robust patent strategy to protect that investment, prevent reverse-engineering, and minimize design-arounds. The World Intellectual Property Organization (WIPO) created The Standing Committee on the Law of Patents (SCP) in 1998 to focus on substantive patent law harmonization. 1 In November 2000, the SCP began focusing their efforts on a Substantive Patent Law Treaty (SPLT). The ultimate goal of the SPLT is global harmonization of issues relating to the grant of patents in order to improve global patent quality. Although the SPLT negotiations were put on hold in 2006,

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.